Syngle Therapeutics
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.syngletherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Syngle Therapeutics
Syngle Therapeutics is a biotech company dedicated to developing an immunotherapy for the treatment of Parkinson's disease. The company focuses on creating antibodies that specifically target oligomeric species of alpha-synuclein, which are implicated in the pathology of Parkinson's. With a gene therapy approach, Syngle aims to enable the brain to produce these antibodies, potentially offering a long-lasting treatment solution. Their innovative research is supported by grants and aims to address the needs of the over 10 million people living with Parkinson's disease worldwide.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Syngle Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Syngle Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Syngle Therapeutics launches new products
Check if Syngle Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Syngle Therapeutics
Funding: Get notified immidiatlly once Syngle Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Check out if Syngle Therapeutics is spiking on competitors!
Earning: See what the market has to say on Syngle Therapeutics recently announced quarterly report
Click to see if Syngle Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Syngle Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Syngle Therapeutics
Compare insights from companies similar to Syngle Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Syngle Therapeutics
<$5M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
Syngle Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Syngle Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Syngle Therapeutics.
Syngle Therapeutics Tech Stack
A closer look at the technologies used by Syngle Therapeutics
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Syngle Therapeutics
Sign Up For FreeTo access detailed company insights
Syngle Therapeutics is a biotech company dedicated to developing an immunotherapy for the treatment of Parkinson's disease. The company focuses on creating antibodies that specifically target oligomeric species of alpha-synuclein, which are implicated in the pathology of Parkinson's. With a gene therapy approach, Syngle aims to enable the brain to... Read More
